HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Michael S. Mulligan Permission Requests Citing Articles Citing Articles via HighWire Google Scholar Articles by McCourtie, A. S. Articles by Mulligan, M. S. PubMed Articles by McCourtie, A. S. Articles by Mulligan, M. S. Related Collections Lung - other Related Article

---

Original Articles: General Thoracic

Alveolar Macrophage Secretory Products Augment the Response of Rat Pulmonary Artery Endothelial Cells to Hypoxia and Reoxygenation

^a Department of Surgery, Division of Cardiothoracic Surgery, University of Washington Medical Center, Seattle, Washington
^b Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Washington Medical Center, Seattle, Washington

Accepted for publication October 16, 2007.

^_* Address correspondence to Dr Mulligan, Division of Cardiothoracic Surgery, University of Washington Medical Center, Box 356310, 1959 NE Pacific St, Seattle, WA 98195 (Email: msmmd{at}u.washington.edu).

Background: Endothelial cell activation is an important response to ischemia and reperfusion in a variety of vascular beds. Endothelial cells secrete a multitude of proinflammatory mediators and express adhesion molecules that promote leukocyte recruitment into injured tissues. Pulmonary artery endothelial cell response to lung ischemia–reperfusion injury does not appear robust enough to drive the development of lung injury independently. Rather, the alveolar macrophage is the key cell in the development of ischemia–reperfusion injury of the lung. Macrophages are known to be a rich source of inflammatory mediators, but the precise mechanism whereby they amplify injury is unknown. The aim of this study was to determine whether alveolar macrophage secretory products amplify the response of the endothelial cell using an in vitro model of lung reperfusion injury.

Methods: Macrophages were exposed to hypoxia and reoxygenation and the media collected. Cultured endothelial cells were then exposed to macrophage media and maintained at normoxia or subjected to hypoxia and reoxygenation. To assess any reciprocal effects of endothelial cell products on macrophage activation, macrophages were likewise exposed to activated endothelial cell media.

Results: Exposure of endothelial cells to activated alveolar macrophage media enhanced chemokine secretion in response to hypoxia and reoxygenation. In the reciprocal experiment, activated endothelial cell media increased the production of macrophage inflammatory protein 1 from macrophages.

Conclusions: Alveolar macrophages drive the development of lung reperfusion injury, by enhancing the production of proinflammatory chemokines from endothelial cells, which impart a degree of positive feedback on alveolar macrophages.

Related Article

Invited Commentary

James S. Allan
Ann. Thorac. Surg. 2008 85: 1060. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				J. S. Allan Invited Commentary Ann. Thorac. Surg., March 1, 2008; 85(3): 1060 - 1060. [Full Text] [PDF]